232 related articles for article (PubMed ID: 23408039)
1. Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer.
Wang S; Li Q; Wang K; Dai Y; Yang J; Xue S; Han F; Zhang Q; Liu J; Wu W
Clin Transl Oncol; 2013 Oct; 15(10):849-54. PubMed ID: 23408039
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer.
Wang S; Xue S; Dai Y; Yang J; Chen Z; Fang X; Zhou W; Wu W; Li Q
Diagn Pathol; 2012 Nov; 7():159. PubMed ID: 23173870
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of miR-133b predict progression and poor prognosis in patients with urothelial carcinoma of bladder.
Chen X; Wu B; Xu Z; Li S; Tan S; Liu X; Wang K
Cancer Med; 2016 Aug; 5(8):1856-62. PubMed ID: 27292588
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of miR-222 is associated with poor prognosis in bladder cancer.
Zhang DQ; Zhou CK; Jiang XW; Chen J; Shi BK
World J Surg Oncol; 2014 Jul; 12():241. PubMed ID: 25078265
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of microRNA-100 in patients with bladder cancer.
Cao YH; Zhang HH; Xu HF; Duan YJ; Li Q; Huang B
Genet Mol Res; 2015 Dec; 14(4):15948-54. PubMed ID: 26662386
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer.
Xu T; Liu X; Han L; Shen H; Liu L; Shu Y
Clin Transl Oncol; 2014 May; 16(5):469-75. PubMed ID: 24019037
[TBL] [Abstract][Full Text] [Related]
7. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.
Pignot G; Cizeron-Clairac G; Vacher S; Susini A; Tozlu S; Vieillefond A; Zerbib M; Lidereau R; Debre B; Amsellem-Ouazana D; Bieche I
Int J Cancer; 2013 Jun; 132(11):2479-91. PubMed ID: 23169479
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
Li X; Yang H; Tian Q; Liu Y; Weng Y
Neoplasma; 2014; 61(4):453-60. PubMed ID: 24645838
[TBL] [Abstract][Full Text] [Related]
9. Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancer.
Blanca A; Sanchez-Gonzalez A; Requena MJ; Carrasco-Valiente J; Gomez-Gomez E; Cheng L; Cimadamore A; Montironi R; Lopez-Beltran A
APMIS; 2019 Aug; 127(8):545-553. PubMed ID: 31231851
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
11. Expression of miRNA-630 in bladder urothelial carcinoma and its clinical significance.
Wang ZY; Zhang W; Yang JJ; Song DK; Wei JX
J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):705-709. PubMed ID: 27752905
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Increased Expression of MicroRNA-155 in Bladder Cancer and Prognosis.
Wang H; Men CP
Lab Med; 2015; 46(2):118-22. PubMed ID: 25918190
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.
Wang LL; Du LT; Li J; Liu YM; Qu AL; Yang YM; Zhang X; Zheng GX; Wang CX
World J Gastroenterol; 2014 Aug; 20(32):11340-6. PubMed ID: 25170220
[TBL] [Abstract][Full Text] [Related]
14. MiR-576-3p is a novel marker correlated with poor clinical outcome in bladder cancer.
Meng FM; Meng FM; Song XL
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):973-977. PubMed ID: 28338199
[TBL] [Abstract][Full Text] [Related]
15. miR-221/222 cluster expression improves clinical stratification of non-muscle invasive bladder cancer (TaT1) patients' risk for short-term relapse and progression.
Tsikrika FD; Avgeris M; Levis PK; Tokas T; Stravodimos K; Scorilas A
Genes Chromosomes Cancer; 2018 Mar; 57(3):150-161. PubMed ID: 29181884
[TBL] [Abstract][Full Text] [Related]
16. The deregulation of miR-133b is associated with poor prognosis in bladder cancer.
Shi Z; Kadeer A; Wang M; Wen B; Li M; Huang J; Gao Y; Liu E; Liu D; Jia D; Liang C
Pathol Res Pract; 2019 Feb; 215(2):354-357. PubMed ID: 30591241
[TBL] [Abstract][Full Text] [Related]
17. Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment.
Avgeris M; Mavridis K; Tokas T; Stravodimos K; Fragoulis EG; Scorilas A
Carcinogenesis; 2015 May; 36(5):528-37. PubMed ID: 25804644
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
[TBL] [Abstract][Full Text] [Related]
19. Increased miR-141 expression is associated with diagnosis and favorable prognosis of patients with bladder cancer.
Wang XL; Xie HY; Zhu CD; Zhu XF; Cao GX; Chen XH; Xu HF
Tumour Biol; 2015 Feb; 36(2):877-83. PubMed ID: 25304156
[TBL] [Abstract][Full Text] [Related]
20. Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer.
Fang Z; Dai W; Wang X; Chen W; Shen C; Ye G; Li L
Tumour Biol; 2016 Jun; 37(6):8075-82. PubMed ID: 26715266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]